Undocumented patient information: An impediment to quality of care

American Journal of Medicine

Volumn 114, Issue 3, 2003, Pages 211-216

  Cox, Jafna L ^a,c   Zitner, David ^a   Courtney, Krista D ^a   MacDonald, Dara Lee ^a   Paterson, Grace ^a   Cochrane, Bonnie ^b   Mathers, Jim ^a   Merry, Heather ^a   Flowerdew, Gordon ^a   Johnstone, David E ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANADA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DOCUMENTATION; FEMALE; HEALTH CARE; HEART FAILURE; HEART INFARCTION; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL AUDIT; MEDICAL RECORD; PATIENT INFORMATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING;

EID: 0037440709     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01481-X     Document Type: Article

References (33)

1. Pearson TA, Peters TD. The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient. Am J Cardiol. 1997;80:45H-52H.
2. Cox JL, on behalf of the ICONS Investigators. Optimizing disease management at a health care system level: the rationale and methods of the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study. Can J Cardiol. 1999;15:787-796.
3. Becker RC, Burns M, Gore JM, et al. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. Am Heart J. 1998;135:786-796.
4. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of 3-blockers for the treatment of elderly patients after acute myocardial infarction. National Cooperative Cardiovascular Project. JAMA. 1998;280:623-629.
5. Venturini F, Romero M, Tognoni G. Patterns of practice for acute myocardial infarction in a population from ten countries. Eur J Clin Pharmacol. 1999;54:877-886.
6. Bart BA, Gattis WA, Diem SJ, O'Connor CM. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol. 1997;79: 1118-1120.
7. Fonarow GC, French WJ, Parsons LS, et al. Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3. Circulation. 2001;103:38-44.
8. Goldman L, Phillips KA, Coxson P, et al. The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol. 2001;38: 1012-1017.
9. Rubenstein LV, Kahn KL, Reinisch EJ, et al. Changes in quality of care for five diseases measured by implicit review, 1981 to 1986. JAMA. 1990;264:1974-1979.
10. Brook RH, McGlynn EA, Cleary PD. Quality of health care. Part 2: measuring quality of care. N Engl J Med. 1996;335:966-970.
11. Luck J, Peabody JW, Dresselhaus TR, et al. How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med. 2000;108:642-649.
12. Ellenbecker CH, Wagner L, Cloutterbuck J. Using insurance claims data and medical record reviews to assess the quality of medical care. J Healthc Qual. 1997;19:21-25, 28-31.
13. Romm FJ, Putnam SM. The validity of the medical record. Med Care. 1981;19:310-315.
14. Sueta CA, Chowdhury M, Boccuzzi SJ, et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1999;83:1303-1307.
15. Hudson JW, Keefe CW, Hogan AJ. Cholesterol measurement and treatment in community practices. J Fam Pract. 1990;31:139-144.
16. Flanagan DE, Cox P, Paine D, et al. Secondary prevention of coronary heart disease in primary care: a healthy heart initiative. QJM. 1999;92:245-250.
17. Wright J, Strang JR. Reducing the risk after coronary artery bypass surgery: documentation of risk factors and communication between hospital and general practice. Public Health. 1997;111:157-160.
18. Bramlet DA, King H, Young L, et al. Management of hypercholesterolemia: practice patterns for primary care providers and cardiologists. Am J Cardiol. 1997;80(suppl 8B):39H-44H.
19. Stables RH, Choudhury RP, Davies WG, et al. An audit of lipid screening and management in patients undergoing diagnostic cardiac catheterization. Eur Heart J. 1996;17:1657-1662.
20. Liesenfeld B, Heekeren H, Schade G, Hepp KD. Quality of documentation in medical reports of diabetic patients. Int J Qual Health Care. 1996;8:537-542.
21. Van Berkel TF, Boersma H, De Baquer D, et al. Registration and management of smoking behaviour in patients with coronary heart disease. The EUROASPIRE survey. Eur Heart J. 1999;20:1630-1637.
22. ASPIRE Steering Group. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action in Secondary Prevention through Intervention to Reduce Events). Principal results. Heart. 1996;75:334-342.
23. Quality of Care and Outcomes Research in CVD and Stroke Working Group. Measuring and improving quality of care: a report from the American Heart Association/American College of Cardiology First Scientific Forum on Assessment of Healthcare Quality in Cardiovascular Disease and Stroke. Circulation. 2000;101:1483-1493.
24. Wielgosz A, Arango M, Carew M, et al. The Changing Face of Heart Disease and Stroke in Canada 2000. Ottawa, Ontario, Canada: Heart and Stroke Foundation of Canada; 1999.
25. Tsuyuki RT, Teo KK, Ikuta RM, et al. Mortality risk and patterns of practice in 2070 patients with acute myocardial infarction 1987-1992. The relative importance of age, sex, and medical therapy. Chest. 1994;105:1687-1692.
26. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol. 1995;76:570-573.
27. The Clinical Quality Improvement Network (CQIN) Investigators. Mortality risk and patterns of practice in 4,606 acute care patients with congestive heart failure. The relative importance of age, sex and medical therapy. Arch Intern Med. 1996;156:1669-1673.
28. Cox JL. The challenge with tracking health outcomes. Can J Clin Pharmacol. 2001;8(suppl A):10A-16A.
29. Tu JV, Schull MJ, Ferris LE, et al. Problems for clinical judgement: 4. Surviving the report card era. CMAJ. 2001;164:1709-1712.
30. Pearce KA, Furberg CD, Psaty BM, Kirk J. Cost-minimization and the number needed to treat in uncomplicated hypertension. Am J Hypertens. 1998;11:618-629.
31. McMurray J. The health economics of the treatment of hyperlipidemia and hypertension. Am J Hypertens. 1999;12(10 pt 2):99S-104S.
32. Ganz DA, Kuntz KM, Jacobson GA, Avorn J. Cost-effectiveness of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor therapy in older patients with myocardial infarction. Ann Intern Med. 2000;132:833-835.
33. Mosca L, Grundy SM, Judelson D, et al. AHA/ACC Scientific Statement: Consensus Panel Statement. Guide to preventive cardiology for women. American Heart Association/American College of Cardiology. J Am Coll Cardiol. 1999;33:1751-1755.